LOTTE BIOLOGICS

롯데바이오로직스에서 2024년 8월 경력사원 채용을 진행합니다! 8월 21일부터 9월 3일까지 다양한 분야의 경력직 인재를 모집합니다. 모집 분야는 ▲Quality Systems ▲HVAC(Engineering) ▲Automation(Engineering) ▲Utility(Engineering) ▲건설안전(Engineering) ▲Data Science(MSAT) ▲언론·홍보 ▲법무 ▲구매 ▲Business Development 등 총 10개 직무입니다. 롯데바이오로직스와 함께 미래를 만들어갈 유능한 인재를 기다립니다. 많은 관심과 지원 바랍니다. ➡️ https://lnkd.in/gRErv2iv _ LOTTE BIOLOGICS is now hiring experienced professionals! From August 21 to September 3, we will be seeking talented individuals across various fields. We are recruiting for positions in 10 areas, including: ▲Quality Systems ▲HVAC (Engineering) ▲Automation (Engineering) ▲Utility (Engineering) ▲Construction Safety (Engineering) ▲Data Science (MSAT) ▲Media Relations & PR ▲Legal Affairs ▲Procurement ▲Business Development. Interested applicants can apply by following the link ➡️ https://lnkd.in/gRErv2iv We look forward to having talented professionals join us in shaping the future together at LOTTE BIOLOGICS. #LOTTEBIOLOGICS #Biologics #AntibodyDrugConjugates #CDMO #Hiring

We are excited to announce that LOTTE BIOLOGICS will be attending the 2024 China Bio on September 10th and 11th! Find us at booth #1302! We look forward to connecting with potential clients and partners. To schedule a meeting with our team, please use the following PartneringONE link; https://lnkd.in/gpiBNhvR Let's explore new opportunities together at #2024ChinaBio !

Driving the Central New York Biotech economy forward! Four local companies team up to deliver the first major piece of process equipment for the LOTTE BIOLOGICS Antibody Drug Conjugate (ADC) facility opening in Q1 2025! ADC is a class of cancer therapies that deliver payloads directly to cancer cells, acting like a "Biological Missile". With a targeted approach, these therapies often result in less adverse effects to patients as compared to traditional chemotherapy. Advanced manufacturing is thriving at the Syracuse Bio Campus with great partnerships and biotech expertise! ➡️ Feldmeier Equipment, Inc. ➡️ Edinger Trucking ➡️ JPW Companies ➡️ The Hayner Hoyt Corporation #LOTTEBIOLOGICS #ADC #CDMO #Advancedmanufacturing

Learn about the business status and future vision of our Syracuse Bio Campus from Ryan Stelick, the Manufacturing Director at our Syracuse Bio Campus. https://lnkd.in/gFdgj2rA With over 15 years of experience, Ryan is a long-term employee of the Syracuse Bio Campus and a key member of LOTTE BIOLOGICS, exemplifying our team’s expertise and commitment to excellence. Over 460 staff members with an average tenure exceeding 10 years are currently employed at our Syracuse Bio Campus, highlighting our specialized and experienced workforce dedicated to biomanufacturing. The facility has achieved over 62 production approvals from Health Authorities worldwide including the FDA, EMA, and PMDA. Leveraging more than 18 years of Drug Substance manufacturing expertise at the Syracuse Bio Campus, LOTTE BIOLOGICS plans to offer optimized ADC Conjugation services tailored to our clients' needs. The ongoing expansion of our ADC production facility is expected to be completed by Q4 2024, with GMP approval targeted for Q1 2025. Please visit the links below to learn more about our services at the Syracuse Bio Campus. ➡️ Syracuse Bio Campus: https://lnkd.in/gxDEH-iG ➡️ ADC Conjugation Service: https://lnkd.in/gJGEpXmz ➡️ For inquiries: https://lnkd.in/dfCuEFa7 (Please leave a message through the 'Contact us' button)

We would like to sincerely thank everyone who joined us in celebrating the groundbreaking ceremony of LOTTE BIOLOGICS’ Songdo Bio Campus! Your presence and support made the day truly special. 📹 Highlight Reel: Relive the memorable moments of the day with highlights from the event. Watch the video below to experience the excitement of this significant milestone. 

We are proud to announce that LOTTE BIOLOGICS held the Ground Breaking Ceremony for Plant 1 of our Incheon Songdo Bio Campus on July 3rd. Hosted by LOTTE Group Chairman Dong-Bin Shin and LOTTE BIOLOGICS CEO Richard Lee, we are grateful to all who attended this landmark occasion for our company. LOTTE BIOLOGICS plans to build three Bio Plants in the Songdo IFEZ bio cluster by 2030, with a total antibody pharmaceutical production capacity of 360kL. Through our new Songdo Bio Plant and our Syracuse Bio Plant in New York, LOTTE BIOLOGICS is committed to delivering excellence and is dedicated to improving the lives of patients worldwide as a leading global CDMO. 

We are pleased to announce that LOTTE BIOLOGICS had a successful BIO International 2024 event. Thanks to your strong interest and support, we had the opportunity to engage with approximately 1,500 attendees at our booth.   Your queries and the business meetings we held were crucial in driving our business forward. We remain committed to delivering innovative CDMO services in the biotech industry and growing alongside you.   A heartfelt thank you to everyone who stopped by our booth. We look forward to continuing this exciting journey together.   For more information about LOTTE BIOLOGICS, please visit our website : https://lnkd.in/gKxmCvgS See you at BIO International 2025 in Boston!   #LOTTEBIOLOGICS #BIOInternational2024 #BIO2024 #Biotech #Innovation

Today marks the second anniversary of LOTTE BIOLOGICS, a significant milestone in our journey.🎉 We extend our heartfelt gratitude to our dedicated team and esteemed partners for their unwavering support and commitment. Your contributions have been instrumental in our growth and success. As we celebrate this special occasion, we look forward to many years of outstanding achievements. Together, we will continue to push boundaries, setting new standards of excellence in the biopharmaceutical industry. Here's to a future filled with success, collaboration, and transformative manufacturing innovation. #LOTTEBIOLOGICS #HAPPYANNIVERSARY

Looking for a CDMO partner with end to end solutions? Visit LOTTE BIOLOGICS at #BIO2024! If you’re interested in learning about our capabilities in antibody drug production and our plans to offer #ADC services, visit us at Booth #5121. Our team is ready to connect with you!

LOTTE BIOLOGICS is excited to announce our participation in the BIO International Convention 2024! You can find us at Booth No. 5121, where we will be engaging with a wide range of potential clients to showcase the unique strengths and synergistic capabilities of our Syracuse Bio Campus and Songdo Bio Campus. With these two state-of-the-art facilities, LOTTE BIOLOGICS is well-equipped to meet the diverse needs of our clients, from large-scale antibody drug production to ADC manufacturing. If you're looking to propel your business to success, visit us at Booth No. 5121. Partner with us, and together we will elevate your business to new heights. #LOTTEBIOLOGICS #BIOUSA2024 #BIOInternationalConvention